MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

2018 International Congress

October 5-9, 2018. Hong Kong. Abstracts are presented on the 6th, 7th, and 8th.

View by Title View Sessions
View by Date
Jump to:  [View All] • a b c d e f g h i j k l m n o p q r s t u v w x y z
  • Protective effects of Mucuna pruriens seed on rat brain: A therapeutic potential drug for Parkinson’s disease

    S. Rajput, S. Sinha (New Delhi, India)

  • PROtein, LEucine And vitamin D Enhancing Rehabilitation (PRO-LEADER) in patients with Parkinson’s disease or parkinsonism: A RCT

    M. Barichella, E. Cereda, G. Pinelli, L. Iorio, D. Caroli, I. Masiero, V. Ferri, E. Cassani, C. Bolliri, S. Caronni, P. Ortelli, D. Ferrazzoli, A. Maras, G. Riboldazzi, G. Frazzitta, G. Pezzoli (Milano, Italy)

  • Proteomic analysis of tear-fluid reveals disease-specific patterns in patients with Parkinson’s Disease

    M. Börger, S. Funke, F. Maass, A. Leha, AE. Roser, AK. Wüstemann, M. Bähr, F. Grus, P. Lingor (Göttingen, Germany)

  • PrP as a receptor of alpha-synuclein in the pancreas of patients with synucleinopathies

    I. Martinez-Valbuena (Pamplona, Spain)

  • Psychogenic Palatal Tremor: A Case Report

    A. Tüfekçi, Ç. Hocaoğlu, D. Yanoğlu, K.S. Karataş (Rize, Turkey)

  • Psychosocial Impact of dysarthria: Is speech intelligibility an effective measure outcome?

    C. Atkinson-Clement, A. Letanneux, M. Berthelot, D. Robert, C. Robieux, C. Moreau, G. Baille, A. Eusebio, F. Fluchère, E. Robin, T. Witjas, J.P. Azulay (Aix-en-Provence, France)

  • PTRHD1 loss-of-function mutation in an African family with parkinsonism and intellectual disability

    IJcken, M. van Slegtenhorst, V. Bonifati (Rotterdam, Netherlands)

  • Public Awareness on Parkinson’s disease in Urban Central Asia

    O. Turgunkhujaev, F. Aliyeva, A. Khashimova, A. Mukanova, O. Okhunov, S.H. Ikramova, A.H. Tan, S.Y. Lim (Moscow, Russian Federation)

  • Pulvinar low intensity on susceptibility-weighted imaging may predict cognitive worsening after deep brain stimulation therapy in Parkinson’s disease patients

    K. Matsuura, M. Maeda, M. Satoh, K. Tabei, T. Araki, M. Umino, H. Kajikawa, N. Nakamura, H. Tomimoto (Tsu, Mie, Japan)

  • Pupil evaluation as the test for the clinical manifestations of Parkinson’s disease

    T. Araga, M. Shiraishi, K. Shinohara, Y. Hasegawa (Kawasaki, Japan)

  • « Previous Page
  • 1
  • …
  • 129
  • 130
  • 131
  • 132
  • 133
  • …
  • 177
  • Next Page »
Jump to:  [View All] • a b c d e f g h i j k l m n o p q r s t u v w x y z

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Survey-Based study of marijuana used in Parkinson’s Disease patients
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • The hardest symptoms that bother patients with Parkinson's disease
  • An Apparent Cluster of Parkinson's Disease (PD) in a Golf Community
  • Life expectancy with and without Parkinson’s disease in the general population
    • Help & Support
    • About Us
    • Cookies & Privacy
    • Wiley Job Network
    • Terms & Conditions
    • Advertisers & Agents
    Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
    Wiley